Wellpoint Prilosec program
This article was originally published in The Tan Sheet
Wellpoint expands availability of its discount program for the OTC proton pump inhibitor into Virginia in August with "other geographies to follow," the insurer says during second quarter earnings call. The initiative "allows members, with a doctor's consent, to access a 90-day supply of Prilosec OTC for $16, considerably less than their prescription drug co-payment." Wellpoint launched the coupon plan in California and Georgia in 2003 (1"The Tan Sheet" Aug. 25, 2003, p. 6). The provider has advocated Rx-to-OTC switches in certain categories to lower healthcare costs...
You may also be interested in...
Insurers are increasingly encouraging members to use over-the-counter drugs in place of more expensive prescription options by expanding coverage plans, offering coupons or paying for a member's first supply of an OTC drug. The growing trend reflects a push to contain rising health care costs
Novartis' entrance into the OTC loratadine market in March could set a precedent for the firm to make a similar move with the proton pump inhibitor omeprazole
In this week's podcast version of Five Must-Know Things: planned US drug pricing legislation in focus; solid quarter but no Seagen announcement for Merck & Co; AbbVie’s Gonzalez sounds alarm over US pricing legislation; Alnylam ready to expand in amyloidosis; and Boehringer Ingelheim on global Jardiance strategy.